Regulatory filing 📈 Stocks 🌍 China

Weigao Group Receives HKEX Approval for 48.3 Million H-Share Conversion

The HKEX approved the conversion of 48.3 million unlisted shares for Weigao Group, representing 1.06% of total issued shares, as the company moves toward full H-share circulation.

🕐 1 min read 📰 HKEX

1 assets impacted. Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: 1066.HK → 2/10 (70% confidence).

📊 Affected Assets (1)

1066.HK
Neutral 🤖 70%
📅 Short-term 🌍 CN · Explicit

On 18 November 2026 the Stock Exchange approved listing of 48,300,000 H Shares held by nine shareholders, equal to about 1.06% of the 4,570,632,324 total issued shares. Conversion removes the last unlisted shares and slightly enlarges the H-share free float, which could add minor selling pressure but is small relative to the 4,522,332,324 already-listed H Shares. Completion remains subject to further regulatory procedures, so the near-term price effect is limited.

Catalysts
  • • Exchange approval received 18 November 2026 for conversion and listing of 48,300,000 H Shares
  • • Unlisted shares fall from 1.06% to 0.00% of issued shares, raising H-share float to 100%
Risk Factors
  • • Conversion still subject to other procedures required by the Stock Exchange and domestic and overseas regulators
  • • Up to 1.06% of new tradable shares may create modest overhang if the participating shareholders sell

🎯 Key Takeaways

  • The Stock Exchange granted approval on 18 November 2026 for the listing of 48,300,000 H shares.
  • The conversion involves nine participating shareholders and accounts for 1.06% of the company's total issued shares.
  • Upon completion, the company's unlisted shares will drop to 0%, with H shares representing 100% of the 4,570,632,324 total issued shares.
  • The H-share full circulation remains subject to further procedures required by domestic and overseas regulatory authorities.

📝 Executive Summary

Shandong Weigao Group Medical Polymer has secured approval from the Hong Kong Stock Exchange to convert 48,300,000 unlisted shares into H shares. This move, announced on 20 November 2026, will effectively bring the company's H-share float to 100% by eliminating all remaining unlisted shares.

❓ FAQ

Will this push the share price up or down?

Neither clearly. The approval removes a step toward full H-share circulation, but the newly tradable block is tiny and completion still depends on further regulatory procedures, so the immediate price effect is limited.